These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 603264)

  • 1. [Epidemic parotitis in Italy: results of a 1st vaccination trial].
    Midulla M; Tamburello O; Balducci L; Assensio AM; Finocchiaro M; Chicca A; Sabatino G
    Ann Sclavo; 1977; 19(2):177-86. PubMed ID: 603264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren.
    Christenson B; Heller L; Böttiger M
    J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mumps: efficacy of booster immunization].
    Gassner M; Hess U; Berger R
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2506-10. PubMed ID: 8571103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety, antigenic activity, and epidemiologic effectiveness of live mumps vaccine from strain L-3. II. Antigenic activity and epidemiologic effectiveness].
    Brazhdanov NP; Popov VF; Sokhin AA; Salmin LV; Frolov VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):45-51. PubMed ID: 7245955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of school children with live mumps virus vaccine.
    Furesz J; Nagler FP
    Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody formation following immunization with mono- and bivalent mumps-(measles-)vaccine (author's transl)].
    Sarateanu DE; Allerdist H; Ehrengut W
    Immun Infekt; 1978 Feb; 6(1):33-7. PubMed ID: 627405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
    Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
    Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of vaccination with Czechoslovakian vaccine against parotitis].
    Plesník V; Fedová D; Sejda J; Slonim D; Cervenka P; Walderová O; Marten J; Casný J; Dolezalová D
    Cesk Pediatr; 1984 Sep; 39(9):540-6. PubMed ID: 6509646
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
    Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.
    Castilla J; García Cenoz M; Arriazu M; Fernández-Alonso M; Martínez-Artola V; Etxeberria J; Irisarri F; Barricarte A
    Vaccine; 2009 Mar; 27(15):2089-93. PubMed ID: 19356610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
    Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
    Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reactogenicity and immunogenicity of the Urabe Am 9 live mumps vaccine and persistence of vaccine induced antibodies in healthy young children.
    Ehrengut W; Georges AM; André FE
    J Biol Stand; 1983 Apr; 11(2):105-13. PubMed ID: 6863321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.